Allergies to mRNA-based COVID-19 vaccines rare, generally mild, study finds
Moderna Covid vaccine edges Pfizer in new US research
17 September 2021Vaccinated groups at highest risk of Covid-19 hospitalisation and death identified using new QCovid tool
17 September 2021Allergies to mRNA-based COVID-19 vaccines rare, generally mild, study finds
Allergic reactions to the new mRNA-based COVID-19 vaccines are rare, typically mild and treatable, and they should not deter people from becoming vaccinated, according to research from the Stanford University School of Medicine.
